A Study of Tumor-Treating Fields in Combination With Durvalumab and Gemcitabine/Cisplatin in Biliary Tract Cancers
Abroad (travel likely)Recruiting
Conditions
Biliary Tract Cancers (BTC)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Anhui Provincial Hospital, Hefei, China
Contact: Study coordinator (Lianxin Liu)